However, regulatory T lymphocyte dysfunction is important in the development of atherosclerosis, and ADA treatment in patients with psoriasis vulgaris resulted in a decrease in plasma regulatory cytokines (IL-10, transforming growth factor-β1, and IL-35) [23], indicating the pro-atherosclerotic effects of ADA. The gene discussed is ADA; the disease is psoriasis vulgaris.